Healthconn Corp (6665.TWO) Q1 2024 Earnings Report

Next: Q2 2024

Healthconn Corp

6665.TWO

TWD21.30 -0.23%

Exchange: TWO | Sector: Healthcare | Industry: Medical Care Facilities

Q1 2024

Published: Mar 31, 2024

Earnings Highlights

Revenue of $298.57M down 3.8% year-over-year
EPS of $0.00 increased by 102.4% from previous year
Gross margin of 18.0%
Net income of 106.50K
"No earnings call transcript quotes are available in the dataset for QQ1 2024." - N/A

6665.TWO

Company 6665.TWO

Period Q1 2024

Currency TWD

Report Type Quarterly Earnings

Generated Dec 8, 2025

Executive Summary

Healthconn Corp reported QQ1 2024 revenue of 298.6 million TWD, down 3.8% year-over-year and 53.0% quarter-over-quarter, accompanied by a gross margin of 17.99%. Despite a positive EBITDA of 2.02 million TWD, the quarter showed an operating loss of 4.19 million TWD and a net income of 0.11 million TWD, highlighting an ongoing shift from top-line growth to profitability leverage. The company also displayed solid liquidity with a total asset base of 1.41 billion TWD and a substantial equity cushion (92.54 million? No—the equity stands at 925.375 million TWD) while reporting net debt in negative territory, indicating a cash-rich balance sheet relative to borrowings. Operating cash flow was negative (-14.7 million), and free cash flow was also negative (-17.3 million), driven by working capital movements and other investing activities, signaling near-term cash-burn pressures even as the balance sheet remains resilient.

Key Performance Indicators

Revenue

Decreasing

298.57M

QoQ: -52.99% | YoY: -3.79%

Gross Profit

Decreasing

53.70M

17.99% margin

QoQ: -57.28% | YoY: -6.74%

Operating Income

Decreasing

-4.19M

QoQ: -158.78% | YoY: -94.49%

Net Income

Increasing

106.50K

QoQ: -99.01% | YoY: 102.54%

EPS

Increasing

0.00

QoQ: -99.04% | YoY: 102.42%

Revenue Trend

Margin Analysis

Financial Highlights

Revenue: 298,573,000 TWD; YoY -3.79%, QoQ -52.99%. Gross Profit: 53,704,000 TWD; Gross Margin 17.99%; YoY -6.74%, QoQ -57.28%. Operating Income: -4,185,500 TWD; Margin -1.40%; YoY -94.49%, QoQ -158.78%. EBITDA: 2,016,000 TWD; EBITDA Margin 0.68%. Net Income: 106,500 TWD; Net Margin 0.04%; YoY +102.54%, QoQ -99.01%. EPS: 0.0023 TWD; YoY +102.42%, QoQ -99.04%. Weighted average shares: 45,357,751. Cash flow from operations: -14,703,500 TWD; Free cash flow: -17,321,500 TWD. Balance sheet highlights: total assets 1,413,643,000 TWD; total liabilities 488,268,000 TWD; total stockholders’ equity 925,375,000 TWD. Debt: total debt 190,000,000 TWD; net debt -178,942,000 TWD. Liquidity: current ratio 2.67; quick ratio 2.36; cash ratio 0.912. Valuation signals (as reported): P/B 1.341; P/S 4.15; P/E 2,912.05; Cash flow-based ratios indicate negative free cash flow despite a sizable equity base.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	298.57M	-3.79%	-52.99%
Gross Profit	53.70M	-6.74%	-57.28%
Operating Income	-4.19M	-94.49%	-158.78%
Net Income	106.50K	102.54%	-99.01%
EPS	0.00	102.42%	-99.04%

Key Financial Ratios

Gross Profit Margin

Weak

18.00%

Gross profit margin is below industry norms, profitability concerns

Operating Profit Margin

Weak

-0.01%

Operating margin is below industry norms, profitability concerns

Net Profit Margin

Weak

0.04%

Net profit margin is below industry norms, profitability concerns

Return on Assets

Weak

0.01%

Return on assets suggests inefficient capital allocation

Return on Equity

Weak

0.01%

Return on equity suggests inefficient capital allocation

Current Ratio

Strong

2.67

Current ratio indicates excellent liquidity and financial flexibility

Debt to Equity

Conservative

0.21

Debt-to-equity shows conservative leverage and low financial risk

P/E Ratio

High Growth

2,912.05x

Very high P/E indicates aggressive growth expectations, higher risk

Price to Book

Fair Value

1.34x

Price-to-book ratio reasonable for profitable companies

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q2 2025	547.94	-0.08	+83.5%	View
Q1 2025	273.97	-0.04	-13.7%	View
Q2 2024	298.57	0.00	-51.9%	View
Q1 2024	298.57	0.00	-3.8%	View

Healthconn Corp (6665.TWO) Q1 2024 Earnings Report

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More 6665.TWO Quarterly Reports

6665.TWO

6665.TWO

6665.TWO

Related Financial Data

Sector Analysis: Healthcare

6665.TWO Full Profile

6665.TWO Financial Statements

Earnings Calendar